8-K/A filing — IRADIMED CORP (IRMD)
Filed: 2026-08-18 AccNo: 0001628280-26-057617 Size: 337 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
CORRECTION: iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $91.300M Est
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 31, 2026, 12:16 PM
- Checked
- Jul 31, 2026, 12:15 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
iRadimed Q2 Adj. EPS $0.46 Beats $0.42 Estimate, Sales $20.466M Beat $20.350M Estimate
Read original at benzingaiRadimed Sees Q3 Adj EPS $0.54-$0.59 vs $0.52 Est; Sees Sales $23.000M-$24.500M vs $23.650M Est
Read original at benzingaiRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est
Read original at benzinga